BPC 157: Experimental Peptide Creates Risk for Athletes FDA Compliance for Peptide Therapy and BPC 157 Holt Law Peptides are unproven as health aids. FDA may unleash them anyway FDA's Overreach on Compounded Peptides GOP lawmakers ask RFK Jr. to make FDA unleash risky peptides like BPC 157 The Niche Big news in the peptide world. The FDA has scheduled a formal hearing in July to review 7 peptides including BPC 157 and TB 500 for legal compounding. This isn't approval.